Press releases

All press releases Regulatory

Press release 2026-06-05

Xspray Pharma to host a conference call regarding Nilopki™

Regulatory press release 2026-06-04

Xspray Pharma Receives CRL from U.S. FDA for Nilopki™

Press release 2026-06-03

Xspray Pharma employees fully participate in market priced long term incentive programs, signaling strong confidence ahead

Regulatory press release 2026-05-12

Bulletin from the annual general meeting of Xspray Pharma AB (publ) 12 May 2026

Regulatory press release 2026-04-30

New number of shares and votes in Xspray Pharma after new share issue April 2026

All press releases

Latest report
Interim Report Q1 2026
Subscribe
Get our latest press releases and reports
Subscribe
URL
This field is for validation purposes and should be left unchanged.
Submit to our press releases and get an email every time we publish a press release or report on our website.
Type*
Reports
Press releases
E-mail*

Välj språk*
Swedish
English
When clicked on Send I agree that my personal information will be saved. Read more

Press contact

Jacob Nyberg, IR

+46 70-767 08 83

info@xspray.com

Media

Blake Leitch, CEO

Per Andersson, CSO

Per Andersson, CSO